Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Ardelyx, Inc. - Common Stock (NQ: ARDX ) 5.210 +0.400 (+8.32%) Streaming Delayed Price Updated: 4:00 PM EST, Dec 27, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 7,096,383 Open 4.740 Bid (Size) 5.220 (9) Ask (Size) 5.230 (94) Prev. Close 4.810 Today's Range 4.615 - 5.260 52wk Range 4.320 - 10.13 Shares Outstanding 103,119,010 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Ardelyx to Participate at the Piper Sandler 36th Annual Healthcare Conference November 20, 2024 From Ardelyx, Inc. Via GlobeNewswire Ardelyx Responds to District Court Decision Granting Motion to Dismiss November 08, 2024 Inclusion of oral-only phosphate-lowering therapies in the ESRD PPS will put dialysis patients’ health at risk From Ardelyx, Inc. Via GlobeNewswire Performance YTD -13.88% -13.88% 1 Month -8.44% -8.44% 3 Month -21.65% -21.65% 6 Month -29.59% -29.59% 1 Year -18.85% -18.85% More News Read More Ardelyx to Participate at the 2024 Jefferies London Healthcare Conference November 05, 2024 From Ardelyx, Inc. Via GlobeNewswire Ardelyx Beats Q3 Sales Estimates, Shares Climb October 31, 2024 Via Benzinga Ardelyx's Earnings Outlook October 30, 2024 Via Benzinga 12 Health Care Stocks Moving In Thursday's After-Market Session October 31, 2024 Via Benzinga Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business Update October 31, 2024 From Ardelyx, Inc. Via GlobeNewswire Ardelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual Meeting October 28, 2024 From Ardelyx, Inc. Via GlobeNewswire Ardelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney Week October 24, 2024 From Ardelyx, Inc. Via GlobeNewswire ARDELYX ALERT: Bragar Eagel & Squire, P.C. is Investigating Ardelyx, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm October 22, 2024 From Bragar Eagel & Squire Via GlobeNewswire Ardelyx Announces Launch of Gut Matters: Discoveries and Innovations, a New Podcast for the IBS-C Patient Community October 22, 2024 From Ardelyx, Inc. Via GlobeNewswire Ardelyx Announces the Derek Forfang Patient Advocate Award to Recognize Advocates for the Chronic Kidney Disease Community October 21, 2024 From Ardelyx, Inc. Via GlobeNewswire Ardelyx to Report Third Quarter 2024 Financial Results on October 31, 2024 October 17, 2024 From Ardelyx, Inc. Via GlobeNewswire FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx October 15, 2024 From Faruqi & Faruqi, LLP Via Business Wire Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Chronic Kidney Disease on Dialysis at the American Society of Nephrology’s Kidney Week October 15, 2024 From Ardelyx, Inc. Via GlobeNewswire ARDX DEADLINE TUESDAY: ROSEN, A LEADING LAW FIRM, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important October 15 Deadline in Securities Class Action – ARDX October 13, 2024 From The Rosen Law Firm PA Via GlobeNewswire Rosen Law Firm Urges Ardelyx, Inc. (NASDAQ: ARDX) Stockholders with Large Losses to Contact the Firm for Information About Their Rights October 11, 2024 From Rosen Law Firm Via Business Wire SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Ardelyx October 11, 2024 From Faruqi & Faruqi LLP Via GlobeNewswire ARDX DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important October 15 Deadline in Securities Class Action – ARDX October 10, 2024 From The Rosen Law Firm PA Via GlobeNewswire Ardelyx Announces Publication of a Review Article Exploring the Patient Burden and Therapeutic Landscape of IBS-C in the U.S. in Clinical and Experimental Gastroenterology October 09, 2024 From Ardelyx, Inc. Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino’s, and Ardelyx and Encourages Investors to Contact the Firm October 08, 2024 From Bragar Eagel & Squire Via GlobeNewswire ROSEN, NATIONAL TRIAL LAWYERS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important October 15 Deadline in Securities Class Action – ARDX October 06, 2024 From The Rosen Law Firm PA Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino’s, and Ardelyx and Encourages Investors to Contact the Firm October 04, 2024 From Bragar Eagel & Squire Via GlobeNewswire Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against WEBTOON, Verve, Domino’s, and Ardelyx and Encourages Investors to Contact the Firm September 30, 2024 From Bragar Eagel & Squire Via GlobeNewswire Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Nano Ardelyx, Inc. (ARDX) Investors September 26, 2024 From Kirby McInerney LLP Via Business Wire Stock Quote API & Stock News API supplied by www.cloudquote.io Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
